High Burnout During Pandemic Among Pediatric Oncology/Hematology Providers
Investigators deployed a survey to assess burnout, stress, emotional wellbeing, and pandemic experiences among pediatric hematology/oncology providers and staff.
News
Latest News
Durable B-ALL Control With Allogeneic Transplant After CAR T-Cell Therapy
Investigators sought to assess outcomes following CD19 CAR T-cell therapy in children and young adults who underwent alloHSCT for B-cell acute lymphoblastic leukemia.
Nomogram Shows Effect of Pleural Effusion on Myeloma Outcome
A team of investigators report on their validated nomogram that incorporates pleural effusion into the classification of disease severity in patients with multiple myeloma.
Risk for Cutaneous Squamous Cell Carcinoma Increases With Age
Among patients younger than 49 years, those with actinic keratosis had a nearly 7-times greater likelihood of developing cutaneous squamous cell carcinoma than patients without actinic keratosis.
Trodelvy Gets Accelerated Approval for Urothelial Cancer
The accelerated approval was based on data from the multicenter, open-label, phase 2 TROPHY study.
Prophylactic Ureteral Stenting Linked to Upper Tract Urothelial Carcinoma
In current urological practice, clinicians decide whether to place a ureteral stent or nephrostomy, but evidence-based treatment guidance is needed.
Unplanned Implant Removal Following Treatment for Locally Advanced Breast Cancer
A team of investigators assessed the frequency and timing of unplanned breast implant removal in patients undergoing with mastectomy, reconstruction, and postmastectomy radiation therapy for locally advanced breast cancer.
Prophylactic IVIG Is More Effective in Subgroups of Myeloma
A retrospective, single-center crossover study was conducted that compared rates of infection in patients with multiple myeloma during observation compared with those receiving IVIG.
Risk Factors for Pediatric Hemorrhagic Cystitis Following HCT
Investigators conducted a study to determine the incidence and clinical course of BK virus hemorrhagic cystitis in children undergoing hematopoietic cell transplantation.
Tisotumab Vedotin Under Review for Recurrent or Metastatic Cervical Cancer
Tisotumab vedotin is an investigational antibody-drug conjugate targeted to tissue factor.
Daratumumab Not Cost-Effective for Multiple Myeloma
Researchers sought to determine whether adding daratumumab to standard care for patients with multiple myeloma was a cost-effective option.
Ixazomib in an Oral Triplet Therapy Shows Benefit for Newly Diagnosed Multiple Myeloma
Researchers sought to determine whether adding ixazomib to treatment with lenalidomide plus dexamethasone would give a benefit to patients with newly diagnosed multiple myeloma.
Genome Sequencing: An Alternative for Risk Stratification in Myeloid Cancers
A team of investigators assessed the application of whole-genome sequencing for genomic profiling of patients with acute myeloid leukemia or myelodysplastic syndromes.
Umbralisib Has Favorable Benefit-Risk Profile in Pretreated Patients With Indolent Non-Hodgkin Lymphoma
Investigators conducted a phase IIb study to assess the safety and efficacy of umbralisib 800 mg/d in patients with relapsed or refractory non-Hodgkin lymphoma.
SIRT1 Inhibitor Cambinol Has Antitumor Activity in Multiple Myeloma Cells
Researchers sought to determine whether cambinol would have antitumor activity in multiple myeloma cells.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
